Advisory Committee; Cellular, Tissue, and Gene Therapies Advisory Committee; Renewal

Advisory Committee; Cellular, Tissue, and Gene Therapies Advisory Committee; Renewal The Food and Drug Administration (FDA) is announcing the renewal of the Cellular, Tissue, and Gene Therapies Advisory Committee by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the Cellular, Tissue, and Gene Therapies Advisory Committee for an additional 2 years beyond the charter expiration date. The new charter will be in effect until the October 28, 2028, expiration date. Agency: Health and Human Services Department; Food and Drug Administration. Source: Federal Register Published: 2026-10-14 Original: https://www.federalregister.gov/documents/2026/10/14/2026-20989/advisory-committee-cellular-tissue-and-gene-therapies-advisory-committee-renewal This listing was added to the Notice Nearby public register from a public government source. It is not a Notice Nearby paid publication, affidavit, or placement certificate.